SIRT1 and serum lipopolysaccharide activity: In the present study, SRT2104, a sirt1 activator (Wu et al., 2022), was administered in mice with lethal endotoxemia to investigate the pharmacological significance of SIRT1-autophagy-PKM2 pathway in inflammatory injury.